Editorial by Prof Manolis Tsiknakis, Coordinator of ProCAncer-I project The ProCAncer-I consortium welcomes you to our first newsletter! We are very happy that our project ProCAncer-I on dealing with prostate cancer was funded by the EU and that through its successful...
Newsletter #1
MRI based Artificial Intelligence tools will improve the management of patients with prostate cancer
Βy Prof. Daniele Regge [Chief of the Radiology Unit, Candiolo Cancer Institute, Torino-Italy] and Simone Mazzetti [Candiolo Cancer Institute, Torino-Italy] Prostate cancer is the most frequently diagnosed tumour in Europe with one new cancer detected every...
The major challenge of a common anonymization strategy
Βy Prof Kostas Marias [Foundation for Research and Technology - Hellas (FORTH)], Ioannis Karatzanis [Foundation for Research and Technology - Hellas (FORTH)] and Katerina Nikiforaki [Foundation for Research and Technology - Hellas (FORTH)] Anonymization is an...
Interview with Dr. Nickolas Papanickolaou (Scientific Coordinator of the project) on the vision of the project
Βy Nickolas Papanikolaou [Principal Investigator in Oncologic Imaging at the Fundação Champalimaud] Why did you select prostate cancer as the center of your research? What kind of clinical unmet needs will be addressed in ProCancer-I? Prostate cancer is among the most...
Legal and Ethical Aspects of ProCAncer-I: The Anonymisation of Personal Data
By the legal team of ProCAncer-I, The University of Vienna Department of Innovation and Digitalisation in Law (UNIVIE) Given the innovative nature of the technology being developed in the ProCAncer-I project, complex legal questions have arisen concerning the...
Presentation of partner Radboud UMC – Major Clinical partner of the project
By the Radboud UMC Radboudumc is one of the leading centres for prostate cancer imaging worldwide. Within the ProCAncer-I project, two groups of the Department of Imaging of Radboudumc are represented. The Diagnostic Image Analysis Group (DIAG), under the...
Presentation of partner UNIVIE – Legal partner of the project
By the University of Vienna – Department of Innovation and Digitalisation in Law (UNIVIE) The University of Vienna is the oldest University in the German-speaking world, and the Department of Innovation and Digitalisation in Law is the newest addition to the...
Newsletter #1 Contents
Highlights

AI Improves prostate cancer (PCa) detection: Clinical Validation of AI models
Jun 24, 2025
ProCAncer-I results | Prof. Daniele Regge on clinical validation In this video, we present the results of the clinical validation of AI models that were developed during the ProCAncer-i Project. Clinical validation is a critical step to ensure that AI tools not only...

Εstablishing robust AI Models for prostate cancer (PCa) care through data-driven decision support
Jun 19, 2025
ProCAncer-I results | Prof. Papanikolaou on Prostanet including PI-QUAL Study and tools Since its inception, the ProCAncer-I project has aimed to establish a robust, ethically compliant AI platform—ProstateNet—to revolutionize prostate cancer (PCa) care through...

Podcast Spotlight: How ProCAncer-I is paving the way for data-driven, patient-centric prostate cancer care with AI tools
Jun 5, 2025
In the following AI-generated audio file, ProCAncer-I achievements are described in a simple way. Since its inception, the ProCAncer-I project has been on a mission to transform prostate cancer (PCa) care through advanced AI and ethically compliant data platforms. At...

Podcast Spotlight: The Future of Trustworthy AI in Healthcare
Mar 5, 2025
The role of artificial intelligence (AI) in healthcare is expanding rapidly, but trust remains a crucial barrier to its widespread adoption. The following AI-generated audio file, titled, serves as an example of how AI-driven technologies can contribute to medical research and education.